HCW11-040 is a pembrolizumab-based fusion immunotherapeutic that activates immune cells and eliminates high-oxygen induced senescent cellsBPD is ...

What’s new: Minimal-equipment pulmonary rehab matched traditional gym-based programs in improving exercise capacity, dyspnea, and quality of life for chronic lung disease patients. Why it matters: ...

Walking thousands of steps a day may not offset the harm caused by spending too many hours sitting, a study warns.

Join the Nationwide Neonatal Resuscitation Program Day 2026 to enhance neonatal care and reduce mortality in India.

BACKGROUND: Pulmonary hypertension (PH) is a serious complication of heart failure with preserved ejection fraction (HFpEF), ...

Received regulatory clearance to initiate its Phase 1 clinical trial of IBIO-600 in AustraliaAnnounced a strategic pipeline expansion into ...

How fast you walk can be a vital sign, just like your blood pressure or body temperature, which can reveal a lot about your ...

A 22-year-old woman presents to the primary care office with chief complaints of wheezing, a dry cough, and shortness of breath most nights of the week for the past 4 months.

Iran: President Trump said on social media that Tehran’s official response to the latest American proposal in the negotiations to end the war was TO ...

PolyPid (NASDAQ:PYPD) said its first quarter marked a transition from late-stage clinical development toward regulatory submission and commercial preparation for D-PLEX100, its lead product candidate ...

Mannkind and United Therapeutics are creating an inhaled formulation of ralinepag, an experimental oral PAH treatment.

Exercise and nutrition-based prehabilitation programs reduce length of stay and complications in patients undergoing surgery.